ECEESPE2025 Poster Presentations Reproductive and Developmental Endocrinology (93 abstracts)
"Variable phenotypic expression of NR5A1 mutation in a family: sex development abnormalities and management challenges"
Muhammad Ahmad 1 , Manju Chandwani 1 , Sumana Chatterjee 1 , Toby Candler 1 , Dinesh Giri 1 , Mark Woodward 1,2 , Julie Alderson 1 , Emma Kivuva 1 , Tessa Homfray 1 , Klaus Mohnike 3 & Elizabeth Crowne 1
1University Hospitals of Bristol and Weston, Paediatric Endocrinology, Bristol, United Kingdom; 2Bristol Children’s Hospital, Department of Paediatric Urology, Bristol, United Kingdom; 3Otto Von Guericke University Magdeburg, Magdeburg, Germany
JOINT1882
Steroidogenic Factor 1 (SF-1/NR5A1) is essential for gonadal and adrenal development. Mutations in NR5A1 are associated with differences in sex development (DSD), presenting a broad phenotypic spectrum from asymptomatic carriers to severe DSD. Despite extensive research, the factors influencing these varied clinical manifestations remain unclear. Oligogenic inheritance may contribute, with multiple genetic variants influencing the phenotype. This case highlights a family with a missense NR5A1 mutation and marked phenotypic variability. Twin 2, from a dichorionic diamniotic pregnancy, presented with ambiguous genitalia, while Twin 1 had normal male genitalia. At birth, Twin 2 had Cilitorophallic enlargement (1 cm), a perineal urethral opening, posterior labioscrotal fusion, and bilateral labioscrotal gonads. The mother had an older phenotypically normal male child and a history of unilateral ovarian germ cell tumour. The maternal aunt, born with genital ambiguity, underwent feminizing genitoplasty and was diagnosed with 46XX ovo-testicular DSD due to a heterozygous NR5A1 variant. She underwent gonadectomy at age nine, with histology revealing intratubular neoplasia. A multidisciplinary team, in agreement with the parents, decided to raise the child as female. Gonapeptyl injections were given until nine months of age to prevent further virilisation. Genetic testing is ongoing for the patient’s two male siblings and maternal grandparents. Future management will involve balancing the risks of malignancy and fertility preservation. The mother had both fertility and malignancy, while the maternal aunt showed malignancy at nine years. If the gonads are retained, a screening protocol will be necessary, along with monitoring for virilisation at puberty. Periodic adrenal function assessment will be required due to the risk of late-onset adrenal insufficiency. Additionally, splenic function will need to be monitored, with appropriate vaccinations, given NR5A1’s role in splenic development.
| QF-PCR | No evidence of SRY |
| Karyotype | 46XX |
| (Day 30) | |
| LH | 5.1 IU/l |
| FSH | 9.3 IU/l |
| Testosterone | 2.3 nmol/l |
| AMH | 184.1 pmol/l (Reference female range < 25) |
| Synacthen test | Cortisol 871 nmol/l, ruling out adrenal insufficiency |
| DSD gene panel | Heterozygous NR5A1 missense variant (NM_004959.5: c.274C>T, p.R92W) was identified in Twin 2, matching the maternal aunt’s and later confirmed in the mother. |
| Examination Under Anaesthesia | Common channel leading to a normal urethra, bladder, and appropriately sized vagina, but no uterus. The gonads appeared abnormal, with a fallopian tube-like structure on the left and an epididymis on the right. Both were relocated to the pelvis, and bilateral inguinal hernia repair was performed. |
| Histology | Ovarian tissue with numerous primordial follicles |
Volume 110
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more